You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lenalidomide

Showing 1 - 25 of 1,173
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma (MZL)
  • Chiang Mai, Thailand
    Chiang Mai University
Nov 20, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Lenalidomide
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Selinexor Combined With Lenalidomide and Rituximab in Treatment

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Selinexor combined with lenalidomide and rituximab
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 20, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Based on Quantitative Pharmacology in Patients With Lenalidomide

Recruiting
  • Multiple Myeloma
  • +2 more
    • Jinan, Shandong, China
      the First Affiliated Hospital of Shandong First Medical Universi
    Oct 3, 2023

    Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2023

    Tafasitamab in Combination With Lenalidomide in Patients withR/R

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • Tafasitamab Injection
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    May 31, 2023

    Advanced HCC Trial (Lenalidomide)

    Not yet recruiting
    • Advanced HCC
    • Lenalidomide
    • (no location specified)
    Apr 16, 2023

    Marginal Zone Lymphoma Trial in Tianjin (Obinutuzumab, lenalidomide)

    Recruiting
    • Marginal Zone Lymphoma
    • Obinutuzumab, lenalidomide
    • Tianjin, Tian, China
      Institute of Hematology & Blood Diseases Hospital
    Apr 27, 2023

    B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

    Not yet recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • (no location specified)
    Mar 6, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

    Recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma
    • Lenalidomide combined with G-CHOP (LO CHOP)
    • Xiamen, Fujian, China
      Bing Xu
    Nov 28, 2023

    Multiple Myeloma Trial in Rennes (Blood and bone marrow sampling)

    Completed
    • Multiple Myeloma
    • Blood and bone marrow sampling
    • Rennes, France
      CHU Rennes
    Feb 2, 2023

    Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Discontinuation of maintenance treatment
    • Cork, Ireland
      Cork University Hospital
    May 10, 2023

    Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
    • (no location specified)
    Sep 5, 2023

    Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • Epcoritamab
    • Lenalidomide
    • (no location specified)
    Jan 20, 2023

    Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
    • +7 more
    Jan 9, 2023

    Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

    Not yet recruiting
    • Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2023

    Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)

    Not yet recruiting
    • Non-Hodgkin Lymphoma
    • Cologne, Germany
      University of Cologne
    Oct 14, 2022

    Oral Ulcer Trial in Beijing (Lenalidomide 10 mg)

    Not yet recruiting
    • Oral Ulcer
    • Lenalidomide 10 mg
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 5, 2022

    Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

    Not yet recruiting
    • Multiple Myeloma
    • Lenalidomide
    • +2 more
    • Augusta, Georgia
      Georgia Cancer Center at Augusta University
    Apr 26, 2023

    Obinutuzumab in Combination With Lenalidomide in Relapsed or

    Recruiting
    • Follicular Lymphoma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital ,Chinese Aca
      Apr 27, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • High Dose Methylprednisolone (HDMP)
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 12, 2023

      Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

      Terminated
      • Multiple Myeloma
      • lenalidomide
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2022